MF

Mario Family Funds

North America, New Jersey, United States, Chatham

Description

Mario Family Funds is an investment fund focused on biotechnology companies.

Investor Profile

Mario Family Funds has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (25%)
  • Private Equity (25%)
  • Series B (25%)
  • Series A (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Clinical Trials
  • Health Care
  • Manufacturing
  • Medical Device
  • Robotics
  • Women's
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mario Family Funds frequently co-invest with?

Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
NXT Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
EG
North America, Florida, United States, Gainesville
Co-Investments: 1
Harbert Growth Partners
North America, Virginia, United States, Richmond
Co-Investments: 2
Perella Weinberg
North America, New York, United States, New York
Co-Investments: 1
Virgo Investment Group
North America, California, United States, Redwood Shores
Co-Investments: 1
Morgan Stanley Expansion Capital
North America, New York, United States, New York
Co-Investments: 2
Crestline
North America, Texas, United States, Fort Worth
Co-Investments: 2
Harbert Management Corporation
North America, Alabama, United States, Birmingham
Co-Investments: 1
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 1

What are some of recent deals done by Mario Family Funds?

Clinipace

Morrisville, North Carolina, United States

Clinipace is a clinical research firm that offers integrated clinical research services for biopharmaceutical and medical firms.

BiotechnologyClinical TrialsMedical
Series UnknownMar 28, 2018
Amount Raised: $19,900,000
OrphoMed

Mill Valley, California, United States

OrphoMed is a San Francisco Bay Area pharmaceutical company focused on the development of novel

BiotechnologyMedicalPharmaceutical
Series AMay 24, 2017
Amount Raised: $39,000,000
Femasys

Suwanee, Georgia, United States

Femasys engages in R&D and manufacture of medical devices for women's healthcare.

BiotechnologyHealth CareManufacturingMedical DeviceRoboticsWomen's
Series BApr 29, 2015
Amount Raised: $10,200,000
Clinipace

Morrisville, North Carolina, United States

Clinipace is a clinical research firm that offers integrated clinical research services for biopharmaceutical and medical firms.

BiotechnologyClinical TrialsMedical
Private EquityJan 15, 2015
Amount Raised: $50,000,000